As discussed, engagement of intrinsic apoptosis machinery is implicated in the efficacy of, and resistance to, many established therapies in prostate cancer, including ADT, AR signaling axis targeting, and chemotherapy (Figure 2). The gene discussed is AR; the disease is prostate carcinoma.